Table 1.
Demographic data (N = 53) for the prediction models of the changes in symptom and functioning scores.
| Baseline (Mean ± SD) |
Follow-Up (Mean ± SD) |
Change from Baseline (Mean ± SD) |
p-Value ‡ | |
|---|---|---|---|---|
| Age | 41.06 ± 11.733 | |||
| Duration of illness | 12.09 ± 9.185 | |||
| Sex | ||||
| Male (%) | 13 (24.5) | |||
| Female (%) | 40 (75.5) | |||
| Diagnostic subtype | ||||
| Type I | 31 (58.5) | |||
| Type II | 22 (41.5) | |||
| Medication † | ||||
| Atypical antipsychotics (%) | 35 (72.9) | |||
| Antidepressants (%) | 22 (45.8) | |||
| Mood stabilizers (%) | 37 (77.1) | |||
| Clinical assessment | ||||
| YMRS | 2.91 ± 4.861 | 3.08 ± 4.636 | 0.17 ± 5.049 | 0.8075 |
| MADRS | 9.64 ± 10.273 | 12.47 ± 10.789 | 2.83 ± 8.485 | 0.0187 |
| PANSS | 38.89 ± 11.265 | 40.43 ± 10.445 | 1.55 ± 10.745 | 0.2993 |
| UKU | 3.57 ± 3.208 | 4.42 ± 3.915 | 0.85 ± 3.319 | 0.0682 |
| PSP | 71.57 ± 10.231 | 71.42 ± 9.844 | −0.15 ± 8.880 | 0.9020 |
| GAF | 71.75 ± 10.963 | 70.40 ± 11.394 | −1.36 ± 9.909 | 0.3229 |
YMRS: Young Mania Rating Scale; MADRS: Montgomery–Åsberg Depression Rating Scale; PANSS: Positive and Negative Syndrome Scale; UKU: UKU Side Effects Rating Scale; PSP: Personal and Social Performance Scale; GAF: Global Assessment of Functioning. † The medication data of five participants were missing. ‡ The p-value was obtained using a paired t test.